Abstract Background: Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of mortality globally
doi: 10.1038/nchembio.2079 68 DaiEZhangWCongDKangRWangJTangD
Try to avoid foods that contain added sugars, have trans fats, or are high in sodium
Key Educational Points: Emphasize the experimental nature No clinical trials support this combination Highlight individual compound efficacy Both peptides show strong effects as monotherapies Discuss approved alternatives CagriSema and other studied combinations offer evidence-based options Explain regulatory status Neither compound has FDA approval for metabolic applications as of 2026 Address safety concerns Overlapping side effect profiles create legitimate risks When clients express interest in research peptides, directing them toward compounds with established safety profiles and dosing protocols serves their best interests
Does exercise help break a GLP-1 stall
Historically, each GLP-1 dollar was split roughly like this: Pharma (Lilly/Novo): ~60% PBMs, insurers, wholesalers, pharmacies: up to 40% That 40% is not value-added